Category : Search result: Axovant


Kriya Therapeutics: $1.2B Funding, No Approved Products

Kriya Therapeutics, founded by Shankar Ramaswamy, secures over $1.2B in funding despite having no approved gene therapies. The surge sparks comparisons to brother Vivek's past venture. Read the full analysis.

Page 1 of 1